GeoPolitics Pulse

The Heartbeat of World events

Novo Nordisk launches Wegovy obesity drug semaglutide India weight management 2025

by ·

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates …

​Read More

Related posts:

  1. Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly’s Mounjaro
  2. Novo Nordisk’s Wegovy weight-loss drug approved in China – Reuters
  3. Novo preparing for early launch of weight-loss drug Wegovy in India – Yahoo Finance
  4. Novo Nordisk sells hit weight-loss drug in China—at fraction of US price – Ars Technica
  5. Novo Nordisk inks $812M Deep Apple deal to pursue obesity target – Fierce Biotech